We have located links that may give you full text access.
Manipulation of lipid metabolism during normothermic machine perfusion: Effect of defatting therapies on donor liver functional recovery.
Liver Transplantation 2019 Februrary 29
BACKGROUND: Strategies to increase steatotic donor livers' utilisation are required to tackle the mortality on the transplant waiting list. We aimed to test the efficacy of pharmacological enhancement of the lipid metabolism of human livers during ex-situ normothermic machine perfusion to promote defatting and improve the functional recovery of the organs.
METHODS: Ten livers discarded because of steatosis were allocated to a defatting group that had the perfusate supplemented with a combination of drugs to enhance lipid metabolism or a control group that received perfusion fluid with vehicle only. Steatosis was assessed using tissue homogenate and histological analysis. Markers for lipid oxidation and solubilisation, oxidative injury, inflammation and biliary function were evaluated by ELISA, immunohistochemistry and in-gel protein detection.
RESULTS: Treatment reduced tissue triglycerides by 38% and macrovesicular steatosis by 40% over 6 hours. This effect was driven by increased solubilisation of triglycerides (p=0.04); and mitochondrial oxidation as assessed by increased ketogenesis (p=0.008) and adenosine triphosphate synthesis (p=0.01) associated with raised levels of the enzymes ACOX-1, CPT1A and acetyl-CoA synthetase. Concomitantly, defatted livers exhibited enhanced metabolic functional parameters such as urea production (p=0.03), lower vascular resistance, lower release of alanine aminotransferase (p=0.049) and higher bile production (p=0.008) with a higher bile pH (p=0.03). The treatment downregulated the expression of markers for oxidative injury, activation of immune cells (CD-14; CD-11b) and reduced the release of inflammatory cytokines in the perfusate (TNF-α; IL-1β).
CONCLUSION: Pharmacological enhancement of intracellular lipid metabolism during normothermic machine perfusion decreased the lipid content of human livers within 6 hours. It also improved the intracellular metabolic support to the organs leading to successful functional recovery and decreased expression of markers of reperfusion injury. This article is protected by copyright. All rights reserved.
METHODS: Ten livers discarded because of steatosis were allocated to a defatting group that had the perfusate supplemented with a combination of drugs to enhance lipid metabolism or a control group that received perfusion fluid with vehicle only. Steatosis was assessed using tissue homogenate and histological analysis. Markers for lipid oxidation and solubilisation, oxidative injury, inflammation and biliary function were evaluated by ELISA, immunohistochemistry and in-gel protein detection.
RESULTS: Treatment reduced tissue triglycerides by 38% and macrovesicular steatosis by 40% over 6 hours. This effect was driven by increased solubilisation of triglycerides (p=0.04); and mitochondrial oxidation as assessed by increased ketogenesis (p=0.008) and adenosine triphosphate synthesis (p=0.01) associated with raised levels of the enzymes ACOX-1, CPT1A and acetyl-CoA synthetase. Concomitantly, defatted livers exhibited enhanced metabolic functional parameters such as urea production (p=0.03), lower vascular resistance, lower release of alanine aminotransferase (p=0.049) and higher bile production (p=0.008) with a higher bile pH (p=0.03). The treatment downregulated the expression of markers for oxidative injury, activation of immune cells (CD-14; CD-11b) and reduced the release of inflammatory cytokines in the perfusate (TNF-α; IL-1β).
CONCLUSION: Pharmacological enhancement of intracellular lipid metabolism during normothermic machine perfusion decreased the lipid content of human livers within 6 hours. It also improved the intracellular metabolic support to the organs leading to successful functional recovery and decreased expression of markers of reperfusion injury. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app